The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Volcano's revenues will grow 2.6% and EPS will shrink to a loss.
The average estimate for revenue is $97.9 million. On the bottom line, the average EPS estimate is -$0.01.
Last quarter, Volcano reported revenue of $93.2 million. GAAP reported sales were 3.2% higher than the prior-year quarter's $90.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
Last quarter, non-GAAP EPS came in at $0.02. GAAP EPS were -$0.06 for Q1 against $0.00 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the preceding quarter, gross margin was 64.5%, 280 basis points worse than the prior-year quarter. Operating margin was -0.2%, 230 basis points worse than the prior-year quarter. Net margin was -3.4%, 370 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $395.8 million. The average EPS estimate is $0.05.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 166 members out of 192 rating the stock outperform, and 26 members rating it underperform. Among 49 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 43 give Volcano a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Volcano is outperform, with an average price target of $27.53.
Is Volcano the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Volcano to My Watchlist.